DOJ: Former Magellan quality control director, execs misled public over lead tests
By 
Adrianne Appel2023-04-11T18:50:00
The former director of quality assurance at Magellan Diagnostics conspired with executives to conceal a critical flaw in lead tests they knew would result in tens of thousands of false negative tests among lead-exposed children, according to the Department of Justice (DOJ).
Reba Daoust, former Magellan director of quality assurance and regulatory affairs; Amy Winslow, former chief executive officer; and Hossein Maleknia, former chief operating officer, repeatedly misled health clinics and the Food and Drug Administration (FDA) about the accuracy of lead-testing devices made by market leader Magellan, according to a grand jury indictment filed April 4 in U.S. District Court for the District of Massachusetts.
Children are considered lead exposed if blood tests show lead above a certain level. Some of the Magellan tests, including LeadCare Ultra and LeadCare II, included a flaw so they inaccurately showed low or no lead levels among children who potentially had lead levels above acceptable limits.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News Brief
Infinity Q founder sentenced to 15 years for fraud scheme
The former chief investment officer and founder of investment adviser Infinity Q Capital Management was sentenced to 15 years in prison and ordered to forfeit $22 million for artificially inflating the values of certain derivatives to defraud investors.
-
News BriefGenotox Laboratories to pay $5.9M in DOJ kickback settlement
Genotox Laboratories agreed to pay at least $5.9 million to settle charges it violated the False Claims Act by paying volume-based commissions to third-party marketers and submitting claims to federal healthcare programs for unnecessary drug tests.
-
News BriefLabcorp to pay $2.1M in third party overbilling case
Laboratory Corporation of America agreed to pay $2.1 million to settle Department of Justice allegations the company overbilled the Department of Defense for genetic tests performed by a third party.
More from Regulatory Enforcement
-
News BriefFTC sues Uber over deceptive subscriptions, a rare move for consumers by Trump officials
The Federal Trade Commission (FTC) filed a lawsuit against Uber, alleging the ride-hailing company signed customers up for its Uber One subscription without consent, then made it hard for them to cancel. The move marks the U.S. government’s latest broadside against big tech companies, and the first major action from ...
-
News BriefCFPB pullback signals further shift toward industry-friendly regulation
The U.S. Consumer Financial Protection Bureau continues to unravel amid pressure from Trump administration officials to shutter the agency. Not only has the agency informed its employees that it will no longer be a watchdog for the financial services industry, it has also laid off employees despite court orders blocking ...
-
News BriefTrump’s CFPB, dismissing Comerica case, continues to cut down Biden-era lawsuits
The Consumer Financial Protection Bureau dropped yet another consumer protection lawsuit against a bank or fintech provider since Donald Trump was sworn in as president in January. This time, it was with Comerica Bank.